…corporate [FDA regulatory route over the Oregon route]…
Psychedelics are useful not for the hallucinations they provide but for the hallucinations they remove…
…the personal journey of hedge fund investor Sa’ad Shah and his involvement… favoring the FDA regulatory route over the Oregon route… “Shah welcomes big pharma and big institutions to enter the fray in the interest of spreading the chemical gospel far and wide. He sees the financial and therapeutic potential for psychedelics not in the cannabis model, which would make psychedelics broadly available for retail purchase, but in the pharmaceutical mode — psychedelics as prescribed drugs, with patent rights, administered in medical settings.” That “with patent rights” bit right there is behind the so-called psychedelic renaissance we’ve been hearing so much about: “favoring the FDA regulatory route over the Oregon route,” as a psychiatrist cited in the article put it. It’s being driven not by the need to free human consciousness from the prohibition-induced coma it’s been under since the sixties so that we can collectively navigate through the many existential hurdles our species is fast approaching with wisdom and insight, but by the agenda to make rich people even richer by forcefully controlling psychedelic substances via the pharmaceutical industry… the gamble appears to be premised on building a high fence to keep everyone playing in the shallow end of the pool, where they are useful.
Original Article (caitlinjohnstone):
The ‘psychedelic renaissance’ is entirely about corporate greed
Artwork Fair Use: Gary Halvorson
Recent Comments